RadNet, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $RDNT in the last 30 days.
See all $RDNT insider activity →RadNet (RDNT) partnered with WIN-NextGen to introduce students to medical imaging careers, addressing workforce shortages. The program offers mentorship, digital learning, and hands-on experiences. RDNT shares traded between $50.82 and $85.84 over the past year, closing at $68.94, down 2.42%.
Guardant Health, RadNet (NASDAQ:RDNT), Labcorp (NYSE:LH), NeoGenomics (NASDAQ:NEO), and Quest (NYSE:DGX) reported Q2 results. RadNet saw 25% revenue growth, beating estimates. Labcorp's revenue grew 5.8%, meeting expectations but underperforming peers. NeoGenomics and Quest both beat estimates with 11.2% and 10.2% revenue growth, respectively. Stocks have risen since reporting.
RadNet (RDNT) reported Q2 2026 revenue of $622.7M, up 25% YoY, and raised full-year guidance. Profit growth lagged, with net income falling to $7.5M from $14.5M YoY. Digital Health revenue grew 56.5%, but its EBITDA dropped 27.2%. Hedge fund ownership declined, while short interest remains high at 14.56%.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning RDNT (RadNet, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent RDNT coverage spans earnings, market movers and financial news.
The collaboration is a modest PR/education initiative with limited financial impact.
Positive earnings beat and strong revenue growth likely support further upside.
Revenue beat and raised guidance may support upside, but widening loss and higher interest expense create downside risk.
The raised revenue estimate is a positive earnings-related update supporting the stock.
RDNT’s guidance raise is a direct fundamental catalyst supporting the stock.
AlphAI scores every news story that mentions RDNT with an AI model for sentiment and relevance, and aggregates insider trades from RadNet, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
RadNet (RDNT) partnered with WIN-NextGen to introduce students to medical imaging careers, addressing workforce shortages. The program offers mentorship, digital learning, and hands-on experiences. RDNT shares traded between $50.82 and $85.84 over the past year, closing at $68.94, down 2.42%.
1 min readGuardant Health, RadNet (NASDAQ:RDNT), Labcorp (NYSE:LH), NeoGenomics (NASDAQ:NEO), and Quest (NYSE:DGX) reported Q2 results. RadNet saw 25% revenue growth, beating estimates. Labcorp's revenue grew 5.8%, meeting expectations but underperforming peers. NeoGenomics and Quest both beat estimates with 11.2% and 10.2% revenue growth, respectively. Stocks have risen since reporting.
3 min readRadNet (RDNT) reported Q2 2026 revenue of $622.7M, up 25% YoY, and raised full-year guidance. Profit growth lagged, with net income falling to $7.5M from $14.5M YoY. Digital Health revenue grew 56.5%, but its EBITDA dropped 27.2%. Hedge fund ownership declined, while short interest remains high at 14.56%.
3 min readWTI crude oil (CLU26) jumped over 5% as Iran and Oman stayed short of a deal to reopen the Strait of Hormuz, with Iran linking reopening to US sanctions, force withdrawal, asset release and compensation. Trump said he would seek compensation from Iran. US rate-hike odds rose; stocks fell, with energy up and airlines, homebuilders down.
5 min readUS stocks were mixed as higher WTI crude pushed up Treasury yields. The 10-year T-note yield rose to 4.690% and was pressured by inflation expectations and a $125B Treasury auction. Markets priced a 47% chance of a +25 bp Fed hike and an 87% chance of an ECB hike. Company movers included DDOG, PLTR, APA, HAL, and VREX after a $1.1B acquisition.
7 min readMarkets were pressured as higher WTI crude lifted inflation expectations and pushed US 10-year T-note yields up to 4.680%. Treasury auctions of $125B in notes and bonds added supply pressure. Energy and cybersecurity stocks rose with crude, while several companies fell on guidance, downgrades, or offerings, including MNDY, TTD, INTC, and AAPL. VREX surged after Teledyne agreed to buy it for $1.1B.
6 min readRadNet (NASDAQ:RDNT) will report earnings next after market close. The article notes last quarter’s revenue of $575.6M, up 22.1% YoY, but a miss on EPS. For the upcoming quarter, analysts expect revenue growth of 22.1% YoY. It cites an average analyst price target of $89.75 versus $71.57 and mentions peer results from Quest and Guardant Health.
3 min readThe article reports multiple US corporate updates. Barrick Mining said Q2 profit rose 50% to $1.22B, with revenue up 44% to $5.29B, and agreed with Newmont on a $1.95B cash top-up to expand Nevada Gold Mines. Nvidia is working on a $500B AI financing venture; Intel announced a $15B stock offering. It also covers results for Axsome (revenue +46%), Monday.com, RadNet, NESR, and Camtek.
7 min readRadNet, Inc. (RDNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA (1) and Revises Upwards 2026 Financial Guidance Ranges · Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the secon
6 min readRadNet (NASDAQ: RDNT) will report earnings tomorrow after market close. The company previously beat revenue expectations with $575.6 million in revenue, up 22.1% year over year, but missed EPS estimates. For the upcoming quarter, analysts expect revenue growth of 22.1% YoY. The article cites an average analyst price target of $89.75 versus a $71.57 share price.
4 min read
